Array BioPharma To Present At The Stifel 2016 Healthcare And Jefferies 2016 Global Healthcare Conferences
November 08 2016 - 2:00PM
PR Newswire (US)
BOULDER, Colo., Nov. 8, 2016 /PRNewswire/ -- Array BioPharma Inc.
(Nasdaq: ARRY) today announced that its Chief Executive Officer,
Ron Squarer, will speak at the
following upcoming conferences. The public is welcome to
participate in the conferences through webcasts on the Array
BioPharma website:
www.arraybiopharma.com.
|
Event:
|
Stifel 2016
Healthcare Conference
|
|
Date:
|
Tuesday, November 15,
2016
|
|
Time:
|
10:15 a.m.
Eastern Standard Time
|
|
|
|
Event:
|
Jefferies 2016 Global
Healthcare Conference
|
|
Date:
|
Thursday, November
17, 2016
|
|
Time:
|
5:20 p.m.
Greenwich Mean Time
|
About Array BioPharma
Array BioPharma Inc. is a
biopharmaceutical company focused on the discovery, development and
commercialization of targeted small molecule drugs to treat
patients afflicted with cancer. Five registration studies are
currently advancing related to three cancer drugs. These programs
include binimetinib (MEK162), encorafenib (LGX818) and selumetinib
(AstraZeneca). For more information on Array, please go to
http://www.arraybiopharma.com/.
|
CONTACT:
|
Tricia
Haugeto
|
|
Array BioPharma
Inc.
|
|
303-386-1193
|
|
thaugeto@arraybiopharma.com
|
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/array-biopharma-to-present-at-the-stifel-2016-healthcare-and-jefferies-2016-global-healthcare-conferences-300359249.html
SOURCE Array BioPharma Inc.
Copyright 2016 PR Newswire
Array Technologies (NASDAQ:ARRY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Array Technologies (NASDAQ:ARRY)
Historical Stock Chart
From Apr 2023 to Apr 2024
